Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 5 $ 214,397 $ (208,758) $ 5,644
Balance (in Shares) at Dec. 31, 2019 5,490,038      
Stock-based compensation 372 372
Stock-based compensation (in Shares)      
Sale of common stock, net of costs $ 1 2,673 2,674
Sale of common stock, net of costs (in Shares) 337,944      
Net loss (5,670) (5,670)
Balance at Mar. 31, 2020 $ 6 217,442 (214,428) 3,020
Balance (in Shares) at Mar. 31, 2020 5,827,982      
Stock-based compensation 210 210
Stock-based compensation (in Shares) 5,240      
Issuance of common stock from exercise of pre-funded warrants $ 1 3 4
Issuance of common stock from exercise of pre-funded warrants (in Shares) 1,200,000      
Sale of common stock and pre-funded warrants, net of costs $ 6 52,159 52,165
Sale of common stock and pre-funded warrants, net of costs (in Shares) 6,138,602      
Deemed dividend for warrant down-round protection provision 1 (1)
Net loss (4,625) (4,625)
Balance at Jun. 30, 2020 $ 13 269,815 (219,054) 50,774
Balance (in Shares) at Jun. 30, 2020 13,171,824      
Stock-based compensation 288 288
Stock-based compensation (in Shares) 1,023      
Issuance of common stock from exercise of warrants and stock options   37   37
Issuance of common stock from exercise of warrants and stock options (in Shares) 2,609      
Issuance of common stock from exercise of pre-funded warrants $ 1 1 2
Issuance of common stock from exercise of pre-funded warrants (in Shares) 411,069      
Costs related to prospectus filed on Form S-3   (134)   (134)
Net loss (5,540) (5,540)
Balance at Sep. 30, 2020 $ 14 270,007 (224,594) 45,427
Balance (in Shares) at Sep. 30, 2020 13,586,525      
Balance at Dec. 31, 2020 $ 18 292,275 (230,974) 61,319
Balance (in Shares) at Dec. 31, 2020 17,532,893      
Stock-based compensation 376 376
Stock-based compensation (in Shares)      
Sale of common stock, net of costs $ 1 14,360 14,361
Sale of common stock, net of costs (in Shares) 1,712,745      
Net loss (5,320) (5,320)
Balance at Mar. 31, 2021 $ 19 307,011 (236,294) 70,736
Balance (in Shares) at Mar. 31, 2021 19,245,638      
Balance at Dec. 31, 2020 $ 18 292,275 (230,974) 61,319
Balance (in Shares) at Dec. 31, 2020 17,532,893      
Balance at Sep. 30, 2021 $ 22 328,001 (247,738) 80,285
Balance (in Shares) at Sep. 30, 2021 22,030,838      
Balance at Mar. 31, 2021 $ 19 307,011 (236,294) 70,736
Balance (in Shares) at Mar. 31, 2021 19,245,638      
Stock-based compensation 459 459
Stock-based compensation (in Shares) 8,705      
Sale of common stock, net of costs $ 2 14,317 14,319
Sale of common stock, net of costs (in Shares) 1,835,688      
Issuance of shares from exercise of stock options 6 6
Issuance of shares from exercise of stock options (in Shares) 900      
Net loss (5,021) (5,021)
Balance at Jun. 30, 2021 $ 21 321,793 (241,315) 80,499
Balance (in Shares) at Jun. 30, 2021 21,090,931      
Stock-based compensation 412 412
Stock-based compensation (in Shares) 12,601      
Sale of common stock, net of costs $ 1 5,796 5,797
Sale of common stock, net of costs (in Shares) 927,306      
Net loss (6,423) (6,423)
Balance at Sep. 30, 2021 $ 22 $ 328,001 $ (247,738) $ 80,285
Balance (in Shares) at Sep. 30, 2021 22,030,838